The co-founder and a senior director of Bristol Laboratories, one of the country’s leading generic medicine manufacturers, died last Sunday (Feb 14) after contracting coronavirus.
PM Raju was admitted to the Royal Brompton Hospital in London last month after his condition deteriorated following the Covid-19 infection.
He succumbed to complications from the virus, having been in the intensive care unit of the hospital for a month. He was 63 and is survived by his wife, Grace, his two sons, Hanson and Benson and his daughter-in-law, Jisha.
Raju helped found Bristol Laboratories and played a key role in its meteoric growth over the past decade. He was a close friend and associate of T Ramachandran, the founder and chairman and managing director of the company.
The two friends started the business from a small office in Harrow, North London in 1997 and together built an enterprise spanning the UK and Europe.
Ramachandran said: “I can never forget 40 years of unconditional partnership with him being side by side with me and my family in happiness and sorrow.
“He was a brother to me and my wife Sreedevi and a beloved uncle to my daughters. Words will never do justice for the greatness of one soul who touched the lives of everyone he met.”
Both Raju and Ramachandran formed a close association while working for several years at IPCA Laboratories – a large pharmaceutical company based in India.
In 1997, Raju moved to the UK to help Ramachandran set up Bristol Laboratories and had since been overseeing all aspects of the company’s growth as “second in command”.
In a statement, Bristol Laboratories said, “His passion, drive and loyalty towards the business was not just a professional one but a personal commitment to serve and excel in the field.
“He was a caring father, a passionate leader and always a phone call away when you needed him. He never said no to anyone and has left a void in our hearts forever.”
Raju was a respected and popular member of British pharma industry who did much to push innovation and develop new territories for Bristol Laboratories.
A regular presence at industry events, he built strong relationships with wholesalers and community pharmacists who came to rely on Bristol Laboratories’ extensive product portfolio.
Paying tribute, CEO of Sigma Pharmaceuticals Bharat Shah said, “I have known Raju for more than 20 years. I have seen him transform from an export executive in India with IPCA to becoming a very powerful executive with Bristol Labs in the UK.
“He was instrumental in developing Bristol Laboratories into one of the leading generic medicine manufacturers in the UK. He would help everyone in the most polite and effective manner. He will be greatly missed not only in the generics industry in the UK, but also by people who knew him.”
Born in Adoor, in India’s southern state of Kerala, Raju completed his graduation in commerce from Kerala University.
He was the founder and a dedicated member of the Indian Orthodox Church in Hemel Hempstead, serving as the council member of the Diocese of UK-Europe and Africa for several years.
Diocesan Bishop Dr Mathews Mar Thimothios Metropolitan of the Indian Orthodox said: “He always stood as a pillar on my right side for all my missions of the diocese.
Raju also played an important role in helping to establish a Malayalee Christian community in North London.
A religious leader who knew Raju described how he helped members of the community.
“When people (from Kerala) landed in the UK, whoever got in touch with him would always get plenty of help – anything from finding accommodation to finding a job. This has been the case for many years,” he said.
The secretary of the Hemel Hempstead church praised Raju as a “very hard working, soft spoken person and a great role model to everyone”.
